Leadership Title

Director, Center for Lupus and Antiphospholipid

Academic Title

Assistant Professor, Harvard Medical School

Specialty

Rheumatology

Medical School

Mount Sinai School of Medicine, 1986

Internship

Columbia-Presbyterian Medical Center, 1989

Residency

Columbia-Presbyterian Medical Center, 1989

Fellowship

National Institute of Allergy and Infectious Disease, National Institutes of Health, 1993

Certifications

Internal Medicine, 1989

Rheumatology, 2002

Clinical Interests

• antophospholipid antibody syndrome

• arthritis

• cutaneous lupus erythematosus

• pregnancy and rheumatic diseases

• systemic lupus erythematosus

• systemic rheumatic diseases

Dr. Cush is the Director of Clinical Rheumatology for Baylor Research Institute and is a Professor of Medicine and Rheumatology at the Baylor University Medical Center. He is board certified in both internal medicine and rheumatology. He is a Clinical Professor of Internal Medicine at The University of Texas Southwestern Medical School.

Dr Cush is also on the Faculty for MDTV Channel  on Pregnancy and Autoimmune Diseases. Watch him by clicking here

Dr. Cush has been named one of the “Best Doctors in Dallas” by D Magazine for the last 10 years and has more than 27 years of clinical and research experience. Dr. Cush is devoted to patient care and clinical research. Experience, insight and candor have made him a frequently sought after educator and advisor. He has authored more than 100 medical and scientific publications and written two textbooks in Rheumatology (Rheumatology: Diagnosis and Therapeutics and Rheumatoid Arthritis: Early Diagnosis and Treatment).



He is the recipient of numerous awards including the R.B. Hingson Humanitarian Award, Teacher of the Year, Best Doctors in America, Texas Top Docs and Best Doctors in Dallas. He has held national leadership positions with the Arthritis Foundation and the American College of Rheumatology and has served on the Arthritis Advisory Committee for the US Food and Drug Administration.

His prime clinical and research interests include drug safety, biologic therapies and medical education.  He has served on the Arthritis Advisory Committee of the U.S. Food and Drug Administration and is the past editor of the American College of Rheumatology (ACR) Hotline series and is the current editor of the ACR Drug Safety Quarterly publication.

Publications

1. Cush JJ. Safety overview of new disease-modifying anti-rheumatic drugs. Rheum Dis Clin North Amer 2004;30:237–55.
2. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulphate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795–808.
3. Cush JJ. Early rheumatoid arthritis — is there a window of opportunity?  J Rheumatol Suppl. 2007 Nov;80:1-7
4. Cush JJ. Kavanaugh A.  TNF-α blocking therapies. In Rheumatology,  M.C Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman (Eds.), 4^th Edition, Spain.  Elsevier, 2007, pp. 501-517
5. Cush JJ, L Calabrese, Kavanaugh A. Prevention of Herpes Zoster (Shingles) in Immunosuppressed Patients.  Hotline. American College of Rheumatology. July 2008
6. American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs.  Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum. 2008 Aug 15;59(8):1058-73.
7. Ali YM, Kuriya B, Orozco C, Cush JJ, Keystone EC.  Can tumor necrosis factor inhibitors be safely used in pregnancy? J Rheumatol. 2010 Jan;37(1):9-17.

Books

• Cush JJ, Kavanaugh A, Stein CM.  Rheumatology: Diagnosis and Therapeutics. J. J. Cush, A.  Kavanaugh, C.M. Stein (Eds.), 2^nd edition, Lippincott, Williams & Wilkins, Philadelphia, 2005
• Cush JJ, Weinblatt ME,  Kavanaugh A.  Rheumatoid Arthritis: Early Diagnosis and Treatment. J. J. Cush, M.E. Weinblatt, A. Kavanaugh (Eds.), 3^rd edition, Professional Communications, New York,  2010

Department / Division
Medicine / Medicine-Rheumatology and Immunology

Address
DUMC 3535
Durham, NC 27710

Appointment Telephone
919-613-2243

Office Telephone
919-681-2045

Fax Telephone
919-681-8298

• MD, Vanderbilt University School of Medicine (Tennessee), 1999

• Internal Medicine, Johns Hopkins Hospital (Maryland), 1999-2002

• Rheumatology, Johns Hopkins Hospital (Maryland), 2002-2005

• MPH, University of California–Los Angeles, 1993-1994

Clinical Interests
Pregnancy in women with rheumatic disease, lupus, antiphospholipid syndrome, inflammatory arthritis, vasculitis

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• Novella Clinical Research
• UCB Pharma

Representative Publications
Clowse, ME; Magder, LS; Petri, M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. Journal of Rheumatology. 2011;38:1012-1016. (2011) Abstract

Crochet, JR; Yeh, JS; Clowse, ME; Copland, SD. Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis. Fertility and Sterility. 2011;95:1786.e13-1786.e16. (2011) Abstract

Clowse, ME. Managing contraception and pregnancy in the rheumatologic diseases. Best Practice and Research: Clinical Rheumatology. 2010;24:373-385. (2010) Abstract

Clowse, ME. The use of anti-TNF¿ medications for rheumatologic disease in pregnancy. International Journal of Women's Health. 2010;2:199-209. (2010) Abstract

Mitchell, K; Kaul, M; Clowse, ME. The management of rheumatic diseases in pregnancy. Scandinavian Journal of Rheumatology. 2010;39:99-108. (2010) Abstract

Clowse, ME; Jamison, M; Myers, E; James, AH. A national study of the complications of lupus in pregnancy. American Journal of Obstetrics and Gynecology. 2008;199:127.e1-127.e6. (2008) Abstract

Clowse, ME. Lupus activity in pregnancy. Rheumatic Disease Clinics of North America. 2007;33:237-v. (2007) Abstract

Clowse, ME; Magder, L; Witter, F; Petri, M. Hydroxychloroquine in lupus pregnancy. Arthritis and Rheumatism. 2006;54:3640-3647. (2006) Abstract

Clowse, ME; Magder, LS; Witter, F; Petri, M. Early risk factors for pregnancy loss in lupus. Obstetrics and Gynecology. 2006;107:293-299. (2006) Abstract

Clowse, ME; Magder, L; Petri, M. Cyclophosphamide for lupus during pregnancy. Lupus. 2005;14:593-597. (2005) Abstract

Clowse, ME; Magder, LS; Witter, F; Petri, M. The impact of increased lupus activity on obstetric outcomes. Arthritis and Rheumatism. 2005;52:514-521. (2005) Abstract

Clowse, ME; Wigley, FM. Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis. Journal of Rheumatology. 2003;30:1341-1343. (2003) Abstract

 

Department

Gastroenterology and Hepatology

Medical Schools

Gastroenterology, University of Chicago, Chicago, IL

Rush Medical College, Chicago, IL

Internship

Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL

Residency

Internal Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL

Certifications

American Board of Internal Medicine  Internal Medicine

American Board of Internal Medicine  Gastroenterology

Academic Rank

Professor of Medicine

Interests

• Inflammatory bowel diseases, specifically, women's issues in IBD including pregnancy and infertility and medication compliance issues

• Patient registries for pregnancy and birth outcomes, and Tysabri use

• Validation study of a novel tool to screen patients for nonadherence to medications

• Study of stool proteins to predict inflammation and disease activity in IBD

Professional Highlights

• Chair, Patient Education Committee, Crohn's and Colitis Foundation of America, 2008-2011

• Chair, Women's Committee of the American College of Gastroenterology, 20042008

• Member, Board of Trustees American College of Gastroenterology, 2007-2010